ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,751.92
      0.11%
      US Tech 100
      19,496.40
      -0.42%
      Dow Jones
      42,595.41
      1.00%
      Brent Oil
      71.435
      0.68%
      Bitcoin
      66,269.32
      1.67%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Exelixis Inc (EXEL)

      7. Exelixis Inc (EXEL) News

      EXEL

      Exelixis (EXEL)

      Exelixis Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:EXEL
      DateTimeSourceHeadlineSymbolCompany
      09/25/20247:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
      09/23/20244:24PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXELExelixis Inc
      09/16/20248:45AMBusiness WireExelixis Announces Final Results from Phase 3 Pivotal CABINET Study Evaluating Cabozantinib in Advanced Neuroendocrine Tumors Presented at ESMO 2024 and Published in New England Journal of MedicineNASDAQ:EXELExelixis Inc
      09/15/20248:45AMBusiness WireExelixis Presents Final Overall Survival Results from Phase 3 CONTACT-02 Pivotal Study Evaluating Cabozantinib in Combination with an Immune Checkpoint Inhibitor in Metastatic Castration-Resistant Prostate Cancer at ESMO 2024NASDAQ:EXELExelixis Inc
      08/28/20247:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
      08/28/20244:05PMBusiness WireExelixis to Webcast Fireside Chats as Part of Investor Conferences in SeptemberNASDAQ:EXELExelixis Inc
      08/16/20247:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
      08/15/20248:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
      08/14/20247:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
      08/14/20245:01PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXELExelixis Inc
      08/12/20247:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
      08/09/20247:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
      08/09/20247:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
      08/09/20247:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
      08/09/20247:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
      08/09/20245:20PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXELExelixis Inc
      08/09/20245:18PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXELExelixis Inc
      08/08/20245:42PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXELExelixis Inc
      08/07/20244:17PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXELExelixis Inc
      08/07/20244:13PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXELExelixis Inc
      08/07/20244:11PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXELExelixis Inc
      08/06/20245:03PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:EXELExelixis Inc
      08/06/20244:18PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EXELExelixis Inc
      08/06/20244:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EXELExelixis Inc
      08/06/20244:05PMBusiness WireExelixis Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:EXELExelixis Inc
      08/06/20248:30AMBusiness WireExelixis Announces U.S. Food and Drug Administration (FDA) Accepted the Supplemental New Drug Application for Cabozantinib for Patients with Advanced Neuroendocrine TumorsNASDAQ:EXELExelixis Inc
      07/23/20244:05PMBusiness WireExelixis to Release Second Quarter 2024 Financial Results on Tuesday, August 6, 2024NASDAQ:EXELExelixis Inc
      06/06/20248:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
      06/04/20248:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
      06/04/20248:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
       Showing the most relevant articles for your search:NASDAQ:EXEL